Daniel R. Orlando

Daniel R. Orlando

Chief Executive Officer at Alcresta Therapeutics, Inc.

58 year
Health Technology
Consumer Services

Profile

Daniel R.
Orlando
is currently the Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Vericel Corp.
from 2012 to 2019 and the Vice President-Business Development at Takeda Pharmaceuticals U.S.A., Inc. from 1999 to 2012.
He holds an MBA from Florida Atlantic University and an undergraduate degree from the University of Florida.

Daniel R. Orlando active positions

CompaniesPositionStart
Chief Executive Officer 2019-06-16
All active positions of Daniel R. Orlando

Former positions of Daniel R. Orlando

CompaniesPositionEnd
VERICEL CORPORATION Chief Operating Officer 2019-06-13
Corporate Officer/Principal 2012-02-29
See the detail of Daniel R. Orlando's experience

Training of Daniel R. Orlando

Florida Atlantic University Masters Business Admin
University of Florida Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel R. Orlando's experience

Connections

47

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
VERICEL CORPORATION

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Daniel R. Orlando